| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter (T.M.F., S.E., A.T.H.), EX2 5AX Exeter; the Division of Medicine, Imperial College School of Medicine, St. Marys Hospital (M.I.McC.), London; the Department of Medicine, School of Medicine (M.W.), Newcastle-upon-Tyne; Diabetes Research Laboratories, Radcliffe Infirmary (J.C.L.), Oxford; the Departments of Medicine and Clinical Biochemistry, Addenbrookes Hospital (S.O.), Cambridge; the Department of Diabetes and Metabolic Medicine, St. Bartholomews and the Royal London School of Medicine and Dentistry (G.A.H.), London; and the Wellcome Trust Center for Human Genetics, University of Oxford (P.V.S.R., A.J.B., E.C.J., S.M.), Oxford, United Kingdom
Address all correspondence and requests for reprints to: Dr. T. M. Frayling, Department of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, Barrack Road, Exeter, United Kingdom EX2 5AX. E-mail: t.m.frayling{at}exeter.ac.uk
Several studies have identified evidence for linkage between type 2
diabetes and the regions on chromosomes 12 and 20 containing the
maturity-onset diabetes of the young (MODY) genes, hepatocyte nuclear
factor-1
(HNF-1
) and HNF-4
. Two studies examining the HNF-1
region have demonstrated evidence for linkage at genome-wide levels of
significance, whereas four studies examining the HNF-4
locus have
resulted in evidence for linkage at more suggestive levels of
significance. The demonstration of linkage to these regions in
additional patient series will strengthen the evidence that
susceptibility alleles exist at these loci. We therefore assessed the
evidence for linkage to these regions using a large cohort of United
Kingdom Caucasian type 2 diabetes-affected sibling pairs.
A maximum total of 315 affected full sibling pairs were typed for
microsatellite markers across the MODY regions and, in a subset of
families, for markers spanning the whole of chromosome 20. Evidence for
linkage was assessed using a multipoint, mode of inheritance-free
method. Linkage analysis did not reveal any significant evidence for
excess allele sharing at any of the regions studied. Loci contributing
sibling recurrence risks, relative to the general population risk, of
1.75 and 1.25 could be excluded for the HNF-1
and HNF-4
regions,
respectively.
We have not confirmed in United Kingdom Caucasians the evidence for linkage previously reported on 12q and 20q. Our results highlight further the problems of replicating previous positive linkage results across different ethnic groups.
This article has been cited by other articles:
![]() |
A. L. Gloyn, F. Reimann, C. Girard, E. L. Edghill, P. Proks, E. R. Pearson, I. K. Temple, D. J.G. Mackay, J. P.H. Shield, D. Freedenberg, et al. Relapsing diabetes can result from moderately activating mutations in KCNJ11 Hum. Mol. Genet., April 1, 2005; 14(7): 925 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Weedon, K. R. Owen, B. Shields, G. Hitman, M. Walker, M. I. McCarthy, L. D. Love-Gregory, M. A. Permutt, A. T. Hattersley, and T. M. Frayling Common Variants of the Hepatocyte Nuclear Factor-4{alpha} P2 Promoter Are Associated With Type 2 Diabetes in the U.K. Population Diabetes, November 1, 2004; 53(11): 3002 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Tilburg, T. W van Haeften, P. Pearson, and C. Wijmenga Defining the genetic contribution of type 2 diabetes mellitus J. Med. Genet., September 1, 2001; 38(9): 569 - 578. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |